Morgan Stanley’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.2M | Buy |
1,307,156
+484,195
| +59% | +$8.24M | ﹤0.01% | 2695 |
|
|
2025
Q1 | $16.1M | Buy |
822,961
+27,642
| +3% | +$540K | ﹤0.01% | 2914 |
|
|
2024
Q4 | $19.7M | Sell |
795,319
-412,438
| -34% | -$10.2M | ﹤0.01% | 2763 |
|
|
2024
Q3 | $29.6M | Buy |
1,207,757
+403,928
| +50% | +$9.9M | ﹤0.01% | 2396 |
|
|
2024
Q2 | $18.8M | Sell |
803,829
-3,319,746
| -81% | -$77.8M | ﹤0.01% | 2736 |
|
|
2024
Q1 | $136M | Sell |
4,123,575
-4,245,109
| -51% | -$140M | 0.01% | 990 |
|
|
2023
Q4 | $228M | Buy |
8,368,684
+7,846,555
| +1,503% | +$214M | 0.01% | 1074 |
|
|
2023
Q3 | $12.6M | Sell |
522,129
-313,063
| -37% | -$7.53M | ﹤0.01% | 2905 |
|
|
2023
Q2 | $26.7M | Buy |
835,192
+105,064
| +14% | +$3.35M | ﹤0.01% | 2165 |
|
|
2023
Q1 | $22.4M | Buy |
730,128
+81,024
| +12% | +$2.48M | ﹤0.01% | 2303 |
|
|
2022
Q4 | $25.4M | Buy |
649,104
+127,984
| +25% | +$5.01M | ﹤0.01% | 2105 |
|
|
2022
Q3 | $24.8M | Sell |
521,120
-82,370
| -14% | -$3.92M | ﹤0.01% | 1977 |
|
|
2022
Q2 | $23.4M | Buy |
603,490
+52,024
| +9% | +$2.01M | ﹤0.01% | 2116 |
|
|
2022
Q1 | $31.6M | Buy |
551,466
+75,378
| +16% | +$4.32M | ﹤0.01% | 1661 |
|
|
2021
Q4 | $37.9M | Buy |
476,088
+17,464
| +4% | +$1.39M | ﹤0.01% | 1548 |
|
|
2021
Q3 | $39.9M | Buy |
458,624
+156,990
| +52% | +$13.7M | 0.01% | 1454 |
|
|
2021
Q2 | $38.8M | Buy |
301,634
+93,439
| +45% | +$12M | 0.01% | 1513 |
|
|
2021
Q1 | $16.7M | Buy |
208,195
+152,117
| +271% | +$12.2M | ﹤0.01% | 2104 |
|
|
2020
Q4 | $4.58M | Buy |
56,078
+19,487
| +53% | +$1.59M | ﹤0.01% | 3357 |
|
|
2020
Q3 | $901K | Buy |
36,591
+15,891
| +77% | +$391K | ﹤0.01% | 4281 |
|
|
2020
Q2 | $579K | Buy |
20,700
+19,004
| +1,121% | +$532K | ﹤0.01% | 4524 |
|
|
2020
Q1 | $30K | Buy |
+1,696
| New | +$30K | ﹤0.01% | 5659 |
|